Abstract
The work was proposed to discuss method development and validation of the drug Mesalamine by using hydrotropic solubilizing agents. An uncomplicated, accurate, and precise method was developed for the drug Mesalamine in bulk as well as Pharmaceutical dosage form. 5M Urea was used as the hydrotropic solubilizing agent to enhance the solubility of the drug. The maximum wavelength (ʎ max) for Mesalamine was found to be 241nm. The validation was performed as per International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines for Accuracy, linearity, precision, Limit of detection (LOD) and Limit of quantification (LOQ). Percentage recovery (%) of Mesalamine was ascertained to be between 95 to 98%. Linearity for Mesalamine was observed between 2-10 µg/ml. Regression equation y=0.0571x-0.0186, regression coefficient (r²) is 0.9996 for Mesalamine. Inter day and intraday precision were checked, % relative standard deviation values were less than 2 for both the methods. Limit of detection (LOD) and Limit of quantification (LOQ) values were derived using regression equations. LOD value was found to be 0.55 µg/ml. LOQ value was found to be 1.67 µg/ml. The assay of the marketed formulation was performed and the results of the assay were obtained by the proposed method. The results are in between 98-102%. So, the method developed was simple and economical that can be adopted for routine tests.
Full text article
References
ASHP 2021. Mesalamine. Anti-inflammatory agents. Drugs.com. American Society of Health-System Pharmacists. Updated on July 22.
Balaji, J., Shivashankar, M. 2017. Development and validation of RP-UHPLC procedure for estimation of 5-amino salicylic acid in 5-amino salicylic acid rectal suppositories. IOP Conf. Ser.: Mater. Sci. Eng., 263(022025):1–7.
Balsalazide 2003. Balsalazide: increasing the choice for patients with ulcerative colitis. Drugs and Therapy Perspectives, 19(10):1–4.
BNF 2018. British National Formulary. 76th edition. In Pharmaceutical Press, pages 39–41. Published on September 2018. ISBN: 9780857113382.
Finkel, R. R., Ma, C., Cubeddu, L. X. 2009. Lippincott’s Illustrated Reviews: Pharmacology. 4th edition. ISBN: 978-0-7817-7155-9.
Jain, S., et al. 2012. Spectrophotometric Method for Simultaneous Estimation of Mesalamine and Prednisolone in Combined Oral Dosage Form. International Journal of Pharmaceutical Sciences and Research (IJPSR), 3(10):3707–3711.
Morcoss, M. M., et al. 2016. Different Spectrophotometric and TLC-Densitometric Methods for Determination of Mesalazine in the presence of Its Two Toxic Impurities. Chem. Pharm. Bull., 64(9):1268–1274.
NIH 2018. Asacol HD-mesalamine tablet, delayed-release. DailyMed. National Institutes of Health. U. S. National Library of Medicine. Retrieved 30 December 2019.
Prajapati, V. K., et al. 2016. Simultaneous determination of Mesalazine and Rifaximin in Synthetic Mixture using Spectrophotometric technique (Simultaneous Equation Method). Asian Journal of Pharmaceutical Analysis, 6(2):61–67.
Sadasivuni, H., Gundoju, N. R. 2020. Analytical Method Development And Validation Of Canagliflozin Hemihydrate In Bulk And Pharmaceutical Dosage forms. Mukt Shabd Journal, 9(6):1690–1698.
Skoog, D. A., James, F. H., Stanley, C. R. 2007. Principles of Instrumental Analysis. 6th edition. In Belmont, CA: Thomson Brooks/Cole, pages 169–173. ISBN: 978-0-495-01201-6.
Sloka, N., Gurupadayya, B. M., Kumar, C. H. 2010. Sensitive Spectrophotometric Method for the Determination of Mesalamine in Bulk and Pharmaceutical Formulations. Der Pharma Chemica, 2(4):389–396.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.